Impact of breast MRI and PET-CT in breast cancer staging;Apport de l'IRM mammaire et du PET-CT dans le bilan initial du cancer du sein

Revue Medicale Suisse

Volumn 6, Issue 250, 2010, Pages 1076-1080

  Mercier Vogel, Ludivine ^a   Bodmer, Alexandre ^a   Kohlik, Magdalena ^b   Couson, Frédéric ^c  

^a Service d oncologie médicale   (Switzerland)

^b HUG   (Switzerland)

^c Institut de Radiologie ImageRive   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISTANT METASTASIS; ECHOGRAPHY; HIGH RISK PATIENT; HUMAN; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; REVIEW; TUMOR VOLUME;

BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY;

EID: 77953423989     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. National comprehensive cancer network clinical practice guidelines in oncology, www.nccn.org/professionals/physician-gls/f-guldelines.asp
2. Kolb MK, Lichy J, Newhouse JH. Comparaison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: An analysis of 27,825 patient evaluations. Radiology 2002;225:165-75.
3. * Berg AB, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004;233:830-49.
4. Van Goethem M, Schelfout K, Kersschot E, et al. MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component. Eur J Radiol 2007;62:273-82.
5. Kuhl KK, Schradding S, Bieling H, et al. MRI for diagnosis of pure ductal carcinoma in situ: A prospective observational study. Lancet 2007;370:485-92.
6. Hata T, Takahashi H, Watanabe K, et al. Magnetic resonance imaging for preoperative evaluation of breast cancer: A comparative study with mammography and ultrasonography. J Am Coll Surg 2004;198:190-7.
7. Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985;56:979-90.
8. Vaidya JS, Vyas JJ, Chinoy RF, et al. Multicentricity of breast cancer: Whole-organ analysis and clinical implications. Br J Cancer 1996;74:820-4.
9. Peters NHGM, Borel Rinkes IHM, Zuithoff NPA, et al. Meta-Analysis of MR imaging in the diagnosis of breast lesions. Radiology 2008;246:116-24.
10. * Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: Systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 2008;26:3248-58.
11. Mann RM, Hoogeveen YL, Blickman JG, Boetes C. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: A review of existing literature. Breast Cancer Res Treat 2008;107:1-14. (Pubitemid 350179588)
12. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
13. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-32.
14. * Solin LJ, Orel SG, Hwang W-T, Harris EE, Schnall MD. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 2008;26:386-91.
15. * Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007;356:1295-303.
16. Puglisi F, Follador A, Minisini AM, et al. Baseline staging after a new diagnosis of breast cancer: Further evidence of their limited indications. Ann Oncol 2005;16:263-6.
17. Ravaioli A, Pasini G, Polselli A, et al. Staging of breast cancer: New recommended standard procedure. Breast Cancer Res Treat 2002;72:53-60.
18. ** ESMO Clinical recommandations, www.esmo.org/education/ esmo-clinical-recommendations.html
19. * Fuster D, Duch J, Paredes P, et al. Preoperative staging of large primary breast cancer with [18F] Fluorodeoxyglucose positron emission tomography/Computed tomography compared with conventional imaging procedures. J Clin Oncol 2008;26:4746-51.